• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Aiforia’s partner network expands to Canada

AIFORIAAnalyst Comment2025-03-18 09:45
Antti Luiro, Frans-Mikael Rostedt
Discuss

Translation: Original published in Finnish on 03/18/2025 at 10:23 am EET

The company today announced a partnership with the Canadian Quorum Technologies. Based on the announcement, Quorum will act as an integrator in the implementation of Aiforia’s solution and support sales.

The partner channel is important for the company, as building own direct sales in all markets would not, in our view, be practical or financially sensible as the market is forming rapidly. Utilizing integrators also allows Aiforia to ramp up more customers simultaneously.

New partnerships are naturally positive for Aiforia, as they reflect the attractiveness of the company's image analysis solutions in the digital pathology market and improve the prerequisites for winning new customers. Our estimates expect the company to successfully implement its growth strategy, including continuous customer wins and accelerating revenue growth, so the release does not affect our view of the company.

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.

Read more on company page

Key Estimate Figures2025-03-10

202425e26e
Revenue2.94.77.6
growth-%18.9 %65.7 %60.0 %
EBIT (adj.)-12.2-11.9-12.0
EBIT-% (adj.)-427.8 %-252.9 %-158.1 %
EPS (adj.)-0.41-0.36-0.36
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

This trend is a bit strange when you consider, for example, the AP-HP Prostia project, for which Aiforia’s product was selected in the spring...
38 minutes ago
by Salvelinus
4
With current compensation and options, one can live very well in France. How can the board still have confidence and be satisfied with a result...
3 hours ago
by kovatuotto
13
Here is some more negative sentiment on the stock: Aiforia Technologies: Aiforia H1 profit warning triggers downgrade to HOLD - NuWays AG Research...
5 hours ago
by NukkeNukuttaja
19
It is somewhat absurd that with all these years of product development, 60 million burned, 70 employees, a large sales organization, a French...
5 hours ago
by Osmos
32
@Antti_Siltanen made his diagnosis: tough luck for investors : Aiforia: Diagnoosimme on kasvun puutos - Inderes Aiforia issued a profit warning...
6 hours ago
by NukkeNukuttaja
12
Have I misunderstood something, since I’ve been thinking that Aiforia’s revenue from hospitals won is recurring? Now, the declining revenue ...
7 hours ago
by Lateinvest
19
There isn’t really anything extraordinary about the revenue recognition delay. Implementation takes time, and revenue is mainly generated once...
19 hours ago
by Antti Siltanen
41